Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway.
Kawabata H, Ono Y, Tamamura N, Oyama K, Ueda J, Sato H, Takahashi K, Taniue K, Okada T, Fujibayashi S, Hayashi A, Goto T, Enomoto K, Konishi H, Fujiya M, Miyakawa K, Tanino M, Nishikawa Y, Koga D, Watanabe T, Maeda C, Karasaki H, Liss AS, Mizukami Y, Okumura T.
Kawabata H, et al. Among authors: oyama k.
J Gastroenterol. 2022 Mar;57(3):208-220. doi: 10.1007/s00535-021-01846-4. Epub 2022 Jan 11.
J Gastroenterol. 2022.
PMID: 35018527